Edwards-Hunt Group
Patient-Powered Research. Operational Precision. Strategic Intelligence.
At Edwards-Hunt Group (EHG), we bring together the voice of the patient and the rigor of clinical research to deliver high-impact, real-world data solutions. With deep expertise in clinical research operations including biospecimen acquisition, we partner with life sciences companies (diagnostics and pharmaceutical sponsors), clinical research networks—and increasingly, hedge funds and private equity firms—to deliver research that drives both outcomes and investment insight.
We Build Research Solutions That Start With the Patient
Our founder, Alicia Sable-Hunt, RN, brings over 25 years of clinical research and nursing leadership to every engagement. Her approach blends firsthand understanding of the patient journey with a sharp focus on protocol execution, regulatory navigation, and strategic site activation.
Trusted by Non-Profits, Pharma, Diagnostic, CROs, & Investors
We specialize in:
- Patient-centered biospecimen and data collection protocols
- Site feasibility, activation, and patient recruitment strategy
- Real-world evidence programs and registry development
- Clinical infrastructure design for early- and late-phase trials
- Strategic intelligence reporting for hedge funds and private equity firms evaluating clinical assets, research pipelines, and operational risk
Our track record spans rare diseases, oncology, sexual health, infectious diseases, and market-entry support for diagnostics and therapeutics.
Research That Delivers Data & Direction
We believe clinical research should reflect the realities of the people it’s designed to serve. By integrating patient insights into our operational model and offering deep market intelligence, we generate data that is meaningful, reproducible, and strategically aligned with sponsor and investor goals.